YARW
Yarrow Bioscience Inc
NASDAQ · Healthcare · Biotechnology · US
$29.58
+2.53%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$16
- Revenue estimate
- $200.0K
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$2.14
- EPS estimate
- -$11
- Revenue actual
- $97.0K
- Revenue estimate
- $200.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +80.5%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $58
- PT range
- $58 – $58
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026